Association Between Diabetes Mellitus and Hypertension Severity at a Primary Health Care Center in Indonesia:  A Cross-Sectional Study

Asdar Amin; Yuni Asri; Ananda Sagita Maharani

doi:10.61132/vitamin.v4i1.2045

Authors

Asdar Amin Institut Teknologi Sains dan Kesehatan RS dr Soepraoen Kesdam V/Brawijaya Malang
Yuni Asri Institut Teknologi Sains dan Kesehatan RS dr Soepraoen Kesdam V/Brawijaya Malang
Ananda Sagita Maharani Institut Teknologi Sains dan Kesehatan RS dr Soepraoen Kesdam V/Brawijaya Malang

DOI:

https://doi.org/10.61132/vitamin.v4i1.2045

Keywords:

Blood Pressure, Diabetes Mellitus, Hypertension severity, Indonesia, Primary Health Care

Abstract

Background: Hypertension remains a major public health problem, particularly in primary health care settings. The coexistence of diabetes mellitus may contribute to increased hypertension severity; however, evidence from primary care data in Indonesia remains limited. Objective: This study aimed to examine the association between diabetes mellitus and hypertension severity among patients attending a primary health care center in Indonesia. Methods: A cross-sectional study was conducted using secondary data obtained from medical records at a primary health care center in 2025. A total of 84 patients with hypertension were included using total sampling. Hypertension severity was classified into stage 1 and stage 2. Bivariate analysis was performed using the Chi-square test or Fisher’s exact test as appropriate, with statistical significance set at p < 0.05. Data were analyzed using SPSS version 26. Results: Of the 84 participants, 33.3% had diabetes mellitus. Stage 2 hypertension was more prevalent than stage 1 hypertension. Diabetes mellitus was significantly associated with hypertension severity (p = 0.029), with a higher proportion of patients with diabetes mellitus presenting with stage 2 hypertension. Conclusion: Diabetes mellitus was significantly associated with greater hypertension severity in a primary health care setting. These findings highlight the importance of integrated management.

Downloads

Download data is not yet available.

References

Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017). Diabetic kidney disease: Challenges, progress, and possibilities. Clinical Journal of the American Society of Nephrology, 12(12), 2032–2045. https://doi.org/10.2215/CJN.11491116

American Diabetes Association. (2024). Introduction and methodology: Standards of care in diabetes-2024. Diabetes Care, 47(Supplement_1), S1–S4. https://doi.org/10.2337/dc24-SINT

Aminian, A., Zajichek, A., Arterburn, D. E., Wolski, K. E., Brethauer, S. A., Schauer, P. R., Kattan, M. W., & Nissen, S. E. (2019). Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA, 322(13), 1271–1282.

Calhoun, D. A., Schiffrin, E. L., & Flack, J. M. (2019). Resistant hypertension: An update. American Journal of Hypertension, 32(1), 1–3. https://doi.org/10.1093/ajh/hpy156

Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., … White, W. B. (2018). Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association. Hypertension, 72(5), e53–e90. https://doi.org/10.1161/HYP.0000000000000084

ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., … Isaacs, D. (2022). Cardiovascular disease and risk management: Standards of care in diabetes—2023. Diabetes Care, 46(Suppl 1), S158.

Endra, F., Setyawan, B., & Lestari, R. (2022). A study of chronic disease management in Indonesian primary health care. Jurnal Kesehatan Indonesia, 16(1), 472–479.

Febriyanti, R. M., Irawan, A. A., Anggriani, N., & Andriyana, Y. (2025). Challenges in implementing Indonesia’s community-based chronic disease management program (Prolanis): A scoping review. AIMS Public Health, 12(July), 890–915. https://doi.org/10.3934/publichealth.2025045

Geldsetzer, P., Manne-Goehler, J., Marcus, M.-E., Ebert, C., Zhumadilov, Z., Wesseh, C. S., … Jaacks, L. M. (2019). The state of hypertension care in 44 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level data from 1·1 million adults. The Lancet, 394(10199), 652–662. https://doi.org/10.1016/S0140-6736(19)30955-9

Hannah-Shmouni, F., Gubbi, S., Spence, J. D., Stratakis, C. A., & Koch, C. A. (2019). Resistant hypertension: A clinical perspective. Endocrinology and Metabolism Clinics, 48(4), 811–828.

Hezam, A. A. M., Shaghdar, H. B. M., & Chen, L. (2024). The connection between hypertension and diabetes and their role in heart and kidney disease development. Journal of Research in Medical Sciences, 29, 22. https://doi.org/10.4103/jrms.jrms_470_23

Hung, M.-J. (2024). Diabetes, hypertension and cardiovascular disease: Clinical insights, mechanisms and pharmacotherapies. Medicina, 60(4). https://doi.org/10.3390/medicina60040566

Maharani, A. S., Asri, Y., & Fani, R. (2025). Hubungan diabetes mellitus dengan penyakit ginjal kronis pada lansia di Indonesia: Analisis data Survei Kesehatan Indonesia (SKI) 2023. Jurnal Biomedika Nusantara, 5(2), 169–179. https://doi.org/10.31603/bnur.15592

Mahwati, Y., Nurrika, D., & Latief, K. (2022). The determinants of undiagnosed hypertension among Indonesian adults: A cross-sectional study based on the 2014–2015 Indonesia Family Life Survey. Jurnal Kesehatan Indonesia, 10(1), 60–67.

Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature Reviews Nephrology, 16(4), 223–237. https://doi.org/10.1038/s41581-019-0244-2

Ministry of Health Indonesia. (2018). Basic health research (Riskesdas) 2018.

NCD Risk Factor Collaboration (NCD-RisC). (2021). Worldwide trends in hypertension and diabetes comorbidity. The Lancet, 398, 957–980.

NCD Risk Factor Collaboration. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398(10304), 957–980. https://doi.org/10.1016/S0140-6736(21)01330-1

Oktaviyani, P., Salman, S., Happy Nurmalita Sari, M., Frisilia, M., Munazar, M., Satria, A., & Maretalinia, M. (2022). Prevalence and risk factors of hypertension and diabetes mellitus among Indonesian elderly. Jurnal Kesehatan Masyarakat Indonesia, 17(2), 100–110.

Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018). Diabetes, hypertension, and cardiovascular disease: Clinical insights and vascular mechanisms. Canadian Journal of Cardiology, 34(5), 575–584. https://doi.org/10.1016/j.cjca.2017.12.005

Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. (2018). 2018 ESC/ESH guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104. https://doi.org/10.1093/eurheartj/ehy339

Wang, Z., Yang, T., & Fu, H. (2021). Prevalence of diabetes and hypertension and their interaction effects on cardio-cerebrovascular diseases: A cross-sectional study. BMC Public Health, 21(1), 1224. https://doi.org/10.1186/s12889-021-11122-y

Wihatno, E., Asri, Y., Kushayati, N., & Parahita, D. P. (2025). Urban-rural disparities in smoking prevalence, consumption, and indoor smoking habits among older adults in Indonesia. Care: Jurnal Ilmiah Ilmu Kesehatan, 13(1), 30–41.

World Health Organization. (2021). Guideline for the pharmacological treatment of hypertension in adults. World Health Organization.

World Health Organization. (2023). Assessing national capacity for the prevention and control of noncommunicable diseases: Report of the 2021 global survey. World Health Organization.

Zhang, T., Jiang, H., Xu, X., Zhao, Z., & Zhou, M. (2026). Non-communicable disease burden in China, 1990–2023: Evidence from the Global Burden of Disease Study 2023. Chinese Medical Journal, 139(01), 48–57.

Zhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., … Taddei, C. (2016). Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4·4 million participants. The Lancet, 387(10027), 1513–1530.